Jaguar Health exchanges Series Q preferred for $22.7 million royalty interest reduction

Jaguar Animal Health, Inc.

Jaguar Animal Health, Inc.

JAGX

0.00
  • Jaguar Health entered privately negotiated exchange agreements on May 19, 2026 to reduce royalty-interest balances by issuing Series Q Perpetual Preferred Stock to Uptown Capital, formerly Irving Park Capital, and Streeterville Capital.
  • Uptown received 500 Series Q shares in exchange for a USD 12.5 million reduction of the December 2020 royalty interest originally issued in a USD 12 million principal amount.
  • Streeterville received 408 Series Q shares in two exchanges in return for a combined USD 10.2 million reduction of the August 2022 royalty interest originally issued in a USD 12 million principal amount.
  • Each Series Q share has a USD 25,000 stated value, carries no dividends, accrues a 10% annual preferred return payable in additional Series Q shares, and can be exchanged at the company’s option into common stock subject to resale, Nasdaq, and 9.99% ownership limits.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jaguar Health Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-231083), on May 19, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.